All News #Library
Others
Alume Biosciences Begins Dosing of ALM-488 in PIII Pivotal Study
23 Aug 2022 //
PRNEWSWIRE
Alume Biosciences Granted FDA Fast Track Designation Of ALM-488
11 May 2021 //
PRNEWSWIRE

Market Place
Sourcing Support